BRIEF published on 08/14/2024 at 13:05, 1 year 8 months ago Torq Resources Defers Margarita Project Payments Joint Venture Margarita Project Payment Deferral Torq Resources Exploration Investment
BRIEF published on 08/14/2024 at 13:05, 1 year 8 months ago Torq Resources reporte les paiements du projet Margarita Report De Paiement Joint-venture Ressources Torq Projet Margarita Investissement Dans L'exploration
BRIEF published on 08/14/2024 at 12:35, 1 year 8 months ago IFabric Corp. Reports Record Revenues and Strong Performance for Q2 2024 Financial Results Q2 2024 Record Revenues IFabric Corp Intelligent Fabrics
BRIEF published on 08/14/2024 at 12:35, 1 year 8 months ago IFabric Corp. annonce des revenus record et de solides performances pour le deuxième trimestre 2024 Résultats Financiers IFabric Corp T2 2024 Des Revenus Record Tissus Intelligents
BRIEF published on 08/14/2024 at 12:35, 1 year 8 months ago Zomedica Announces Strategic Expansion in Costa Rica with SIRE Veterinario Partnership Global Expansion Strategic Partnership Zomedica Veterinary Health Costa Rica
BRIEF published on 08/14/2024 at 12:35, 1 year 8 months ago Zomedica annonce une expansion stratégique au Costa Rica avec le partenariat SIRE Veterinario Partenariat Stratégique Zomedica Expansion Mondiale Santé Vétérinaire Costa Rica
BRIEF published on 08/14/2024 at 12:27, 1 year 8 months ago CBMJ Exceeds Expectations with 532% Revenue Growth for Q-2, Reduces Share Count by 8.5% Revenue Growth Patriot.TV Stockholders' Equity Share Reduction Q-2 Financials
BRIEF published on 08/14/2024 at 12:27, 1 year 8 months ago CBMJ dépasse les attentes avec une croissance de 532 % des revenus au deuxième trimestre et réduit le nombre d'actions de 8,5 % Capitaux Propres Croissance Des Revenus Patriote.TV Résultats Financiers Du Deuxième Trimestre Réduction Des Parts
BRIEF published on 08/14/2024 at 12:25, 1 year 8 months ago Destiny Pharma Initiates Research to Explore XF Drug Potential for CF Biotechnology Cystic Fibrosis MRSA Drug Research XF-73
BRIEF published on 08/14/2024 at 12:25, 1 year 8 months ago Destiny Pharma lance des recherches pour explorer le potentiel du médicament XF pour la mucoviscidose Biotechnologie XF-73 Fibrose Kystique SARM Recherche Sur Les Médicaments
Published on 04/22/2026 at 01:30, 1 hour 16 minutes ago Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:00, 2 hours 46 minutes ago Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 2 hours 46 minutes ago Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska
Published on 04/21/2026 at 22:15, 4 hours 31 minutes ago Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
Published on 04/21/2026 at 20:50, 5 hours 56 minutes ago CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
Published on 04/21/2026 at 19:15, 7 hours 31 minutes ago Shelly Group SE publishes 2025 Investors Report as an established transparency format
Published on 04/21/2026 at 19:08, 7 hours 38 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/21/2026 at 19:02, 7 hours 44 minutes ago Brockhaus Technologies AG: Actions for annulment and nullity against the approval resolution of the Extraordinary General Meeting of February 26, 2026
Published on 04/21/2026 at 19:15, 7 hours 31 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 19:15, 7 hours 31 minutes ago AXA - Descriptif du programme de rachat d’actions
Published on 04/21/2026 at 18:00, 8 hours 46 minutes ago Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 18:00, 8 hours 46 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mars 2026
